7 results
COVID-19 Coronavirus Disease 2019

Harvard Medical School from Bench to Bedside

#COVID19 #Coronavirus #Pathophysiology #Overview #Diagnosis
COVID-19 Coronavirus ... to Bedside #COVID19 ... #Coronavirus #Pathophysiology
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
virus causing COVID ... ivermectin… #COVID19 ... #Coronavirus #SARS-CoV ... #CriticalCare #EmergencyMedicine
COVID-19 review…here is a list of some of the drugs that are currently being used or
COVID-19 review… ... investigated for COVID ... treatments for COVID ... #CoronaVirus #Treatment ... #CriticalCare #EmergencyMedicine
COVID-19 - How does it affect you? 
Gas Exchange 
Each sac of air, or alveolus, is
COVID-19 - How does ... proteins covering the coronavirus ... process and the new coronaviruses ... azuravesta #COVID19 ... #Pathophysiology
Remdesivir (GS-5734) - manufactured by Gilead Sciences
Remdesivir blocks the replication of viruses by inserting into the
Coronavirus enters ... Importantly, while coronaviruses ... #Pharmacology #Pathophysiology ... #COVID19 #SARSCOV2 ... #Coronavirus
ACEi/ARBs in COVID-19: Beneficial, Bad, or Benign?
Preclinical studies suggest ACEi/ARB use increases ACE2 expression, raising concern
ACEi/ARBs in COVID ... overactivation in COVID ... #ACEi #ARBs #COVID19 ... #SARSCOV2 #Coronavirus ... #Pathophysiology
Respiratory pathogen transmission routes
AEROSOL
 • Solid or liquid particles suspended in air or a gas that
cold) • MERS-coronavirus ... • SARS-CoV-2 (COVID ... routes #aerosols #pathophysiology